(BCSF) Bain Capital Specialty - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US05684B1070
BCSF: Loans, Debt, Securities, Investments
Bain Capital Specialty Finance, Inc. (NYSE:BCSF) is a business development company that focuses on providing direct loans to middle-market companies. The firm specializes in senior secured loans, which are often collateralized by the borrowers assets. These investments include first and second lien loans, unitranche debt, and other structured debt instruments. The company also invests in mezzanine debt and junior securities, as well as secondary purchases of debt portfolios.
BCSF primarily targets companies with EBITDA between $10 million and $150 million. This focus allows the firm to capitalize on the financing needs of middle-market businesses, which often have limited access to capital from traditional sources. The company’s investment strategy is designed to generate attractive risk-adjusted returns through a combination of current income and capital appreciation.
As a publicly traded business development company, BCSF is required to distribute at least 90% of its taxable income to shareholders in the form of dividends. This structure makes it an attractive option for income-focused investors. The firm is managed by Bain Capital Credit, a global credit specialist with a strong track record in middle-market lending. The management team’s expertise in credit underwriting and portfolio management is a key differentiator for BCSF.
From a financial perspective, BCSF has a market capitalization of approximately $1.18 billion, with a price-to-earnings ratio of 9.22 and a forward P/E of 10.38. The stock’s price-to-book ratio is 1.03, indicating that investors are valuing the company roughly in line with its book value. The price-to-sales ratio of 4.02 reflects the firm’s revenue generation capabilities in the asset management space.
Investors considering BCSF should evaluate its ability to maintain a stable dividend payout while navigating the risks associated with middle-market lending. Key considerations include the firm’s portfolio diversification, default rates, and the overall health of the economy. As with any financial institution, the quality of the management team and its ability to adapt to changing market conditions are critical factors for long-term success.
Additional Sources for BCSF Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
BCSF Stock Overview
Market Cap in USD | 1,077m |
Sector | Financial Services |
Industry | Asset Management |
GiC Sub-Industry | Asset Management & Custody Banks |
IPO / Inception | 2018-11-15 |
BCSF Stock Ratings
Growth 5y | 94.2% |
Fundamental | 19.3% |
Dividend | 80.5% |
Rel. Strength | -3.9 |
Analysts | 3.67/5 |
Fair Price Momentum | 19.75 USD |
Fair Price DCF | - |
BCSF Dividends
Dividend Yield 12m | 11.74% |
Yield on Cost 5y | 44.26% |
Annual Growth 5y | 4.83% |
Payout Consistency | 96.9% |
BCSF Growth Ratios
Growth Correlation 3m | -23.2% |
Growth Correlation 12m | 94% |
Growth Correlation 5y | 86.8% |
CAGR 5y | 30.95% |
CAGR/Max DD 5y | 1.16 |
Sharpe Ratio 12m | 1.62 |
Alpha | 5.36 |
Beta | 1.159 |
Volatility | 16.28% |
Current Volume | 397.6k |
Average Volume 20d | 360.1k |
As of April 03, 2025, the stock is trading at USD 16.45 with a total of 397,628 shares traded.
Over the past week, the price has changed by -2.03%, over one month by -9.11%, over three months by -3.78% and over the past year by +17.48%.
Neither. Based on ValueRay Fundamental Analyses, Bain Capital Specialty is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 19.26 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BCSF as of April 2025 is 19.75. This means that BCSF is currently undervalued and has a potential upside of +20.06% (Margin of Safety).
Bain Capital Specialty has received a consensus analysts rating of 3.67. Therefor, it is recommend to hold BCSF.
- Strong Buy: 1
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, BCSF Bain Capital Specialty will be worth about 22.6 in April 2026. The stock is currently trading at 16.45. This means that the stock has a potential upside of +37.08%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 18 | 9.4% |
Analysts Target Price | 16.8 | 2.3% |
ValueRay Target Price | 22.6 | 37.1% |